News

STALICLA announces a new long term research partnership with the Greenwood Genetic Center (GGC)

STALICLA is excited to announce a long-term research partnership with the Greenwood Genetic Center (GGC), a leading translational research center for neurodevelopmental disorders, including autism spectrum disorder (ASD).

Read more

US Food & Drug Administration – Public meeting on Patient-Focused Drug Development Initiative for Autism and workshop

Lynn Durham, CEO & Founder, is participating in patient focused Drug Development meeting organized by FDA being held May 4, 2017.

Read more

Search for content on Stalicla...